Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2004;104:1367-1391
© 2004 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum (v106,p869)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conde-Agudelo, A.
Right arrow Articles by Lindheimer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conde-Agudelo, A.
Right arrow Articles by Lindheimer, M.
Related Collections
Right arrow Epidemiology/public health
Right arrow Hypertension and PIH
Right arrow Meta-analysis
Right arrow Medical complications of pregnancy
Right arrow Obstetric complications of pregnancy
Right arrow Preterm labor

REVIEWS

World Health Organization Systematic Review of Screening Tests for Preeclampsia

Agustin Conde-Agudelo, MD, MPH*, José Villar, MD, MPH{dagger} and Marshall Lindheimer, MD{ddagger}

From the *Department of Obstetrics and Gynecology, Fundacion Clínica Valle del Lili, Cali, Colombia; {dagger}UNDP/UNFPA/WHO/World Bank Special Programme of Research Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland; and {ddagger}Department of Obstetrics & Gynecology and Medicine, The University of Chicago, Chicago, Illinois.

Address reprint requests to: Dr. José Villar, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland; e-mail: villarj{at}who.int.

OBJECTIVE: We sought to assess the usefulness of clinical, biophysical, and biochemical tests in the prediction of preeclampsia.

DATA SOURCES: The sources of data we used to conduct this review included the computerized databases MEDLINE (1966 to February 2003), EMBASE, Popline, CINAHL, and LILACS plus reference lists, conference proceedings, textbooks, and contact with experts.

METHODS OF STUDY SELECTION: All cohort or cross-sectional studies reporting data on the relationship between a predictive test that was performed during pregnancy and the development of preeclampsia were eligible for inclusion, whereas case–control studies were excluded. Eighty-seven (211,369 women) of 7,191 potentially relevant articles met inclusion criteria. We evaluated the methodologic quality for each included study.

TABULATION, INTEGRATION, AND RESULTS: Using a standardized protocol, one reviewer selected and extracted data on study characteristics, quality, and accuracy. Data abstracted from each study were arranged in 2 x 2 tables to construct receiver operating characteristics plots (sensitivity against 1 – specificity) and pooled to produce summary likelihood ratios for positive and negative tests results. Moderate predictive accuracy of anticardiolipin antibodies, the presence of bilateral diastolic notches during Doppler ultrasonography, and urinary kallikrein were found in women at low risk of developing preeclampsia. Nevertheless, because the pretest probability of preeclampsia with a positive result was but minimally increased, the clinical use of these tests is limited. Other ultrasonography characteristics and the measurement of fetal and placental peptides showed low predictive accuracy. In populations that were deemed at high risk for preeclampsia, the use of Doppler ultrasonography had low predictive accuracy. No definitive conclusions were possible in the case of many other tests, because the number of studies that met the minimal inclusion criteria was limited.

CONCLUSION: As of 2004, there is no clinically useful screening test to predict the development of preeclampsia. Further prospective, longitudinal studies are needed.

LEVEL OF EVIDENCE: III




This article has been cited by other articles:


Home page
CMAJHome page
A. Conde-Agudelo MD MPH and M. Lindheimer MD
Use of Doppler ultrasonography to predict pre-eclampsia
Can. Med. Assoc. J., July 1, 2008; 179(1): 53 - 53.
[Full Text] [PDF]


Home page
CMAJHome page
J. S. Cnossen MD, R. K. Morris MD, G. ter Riet MD PhD, B. W.J. Mol MD PhD, J. A.M. van der Post MD PhD, A. Coomarasamy MD, A. H. Zwinderman MSc PhD, S. C. Robson MD, P. J.E. Bindels MD PhD, J. Kleijnen MD PhD, et al.
Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis
Can. Med. Assoc. J., March 11, 2008; 178(6): 701 - 711.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
B. M. Sibai
Caring for Women With Hypertension in Pregnancy
JAMA, October 3, 2007; 298(13): 1566 - 1568.
[Full Text] [PDF]


Home page
Reproductive SciencesHome page
J. V. Ilekis, U. M. Reddy, and J. M. Roberts
Review Article: Preeclampsia A Pressing Problem: An Executive Summary of a National Institute of Child Health and Human Development Workshop
Reproductive Sciences, September 1, 2007; 14(6): 508 - 523.
[Abstract] [PDF]


Home page
Am J EpidemiolHome page
W. M. Callaghan
Invited Commentary: Identifying Women with Hypertension during Pregnancy--Is High Specificity Sufficient?
Am. J. Epidemiol., July 15, 2007; 166(2): 125 - 127.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Rana, S. A. Karumanchi, R. J. Levine, S. Venkatesha, J. A. Rauh-Hain, H. Tamez, and R. Thadhani
Sequential Changes in Antiangiogenic Factors in Early Pregnancy and Risk of Developing Preeclampsia
Hypertension, July 1, 2007; 50(1): 137 - 142.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
M. Widmer, J. Villar, A. Benigni, A. Conde-Agudelo, S. A. Karumanchi, and M. Lindheimer
Mapping the Theories of Preeclampsia and the Role of Angiogenic Factors: A Systematic Review
Obstet. Gynecol., January 1, 2007; 109(1): 168 - 180.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. J. Williams, K. Gumaa, M. Scioscia, C. W. Redman, and T. W. Rademacher
Inositol Phosphoglycan P-Type in Preeclampsia: A Novel Marker?
Hypertension, January 1, 2007; 49(1): 84 - 89.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G.H. Woldringh, M.H.A. Frunt, J.A.M. Kremer, and M.E.A. Spaanderman
Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies
Hum. Reprod., November 1, 2006; 21(11): 2948 - 2954.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. D. Lindheimer and J. G. Umans
Explaining and predicting preeclampsia.
N. Engl. J. Med., September 7, 2006; 355(10): 1056 - 1058.
[Full Text] [PDF]


Home page
Hum ReprodHome page
R. Ganapathy, L.J. Ayling, G.S.J. Whitley, J.E. Cartwright, and B. Thilaganathan
Effect of first-trimester serum from pregnant women with high-resistance uterine artery Doppler resistance on extravillous trophoblast invasion
Hum. Reprod., May 1, 2006; 21(5): 1295 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
J. S. Cnossen, B. W. Mol, J. A. M. van Der Post, P. M. M. Bossuyt, and G. ter Riet
World Health Organization Systematic Review of Screening Tests for Preeclampsia
Obstet. Gynecol., May 1, 2005; 105(5): 1151 - 1152.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Obstetricians and Gynecologists.